the cost of «beauty»
New Fill: Laglenne slows the progress of acces to this drug, used to treat scarring side-effects in AIDS patients.
29
07, 2002
19
07, 2002
What is at stake in access to anti-HIV/AIDS generic medicines?
Since multitherapies were launched, international donors have been claiming that the cost of such medicines is too high for them to pay for the medical care of people living with HIV/AIDS in poor countries. The cost of antiretroviral medicines is a difficult problem, but so is the very high cost of some treatments for opportunistic illnesses(nizorat, [...]
11
07, 2002
COPY = RIGHT: Let poor countries access generic ARVs
Drug companies are using several ways to block generic access in developing countries: 1. patents : drug companies use their patents to stop poor-country governments from making or importing cheap, generic HIV drugs of their own ; 2. company/government agreements : drug companies use pseudo-philanthropic agreements ("Accelerated Access Initiatives") with needy governments in order to force [...]
10
07, 2002
European Union : Where is the US$ 10 billion?
One year after the touted announcement by the G8 of the creation of the Global Fund, the contribution by rich countries, among which most EU Members, is not 10% of original targets. Where is the promised US$ 10 billion ? The Global Fund's coffers have been almost emptied by its first disbursement round.
08
07, 2002
Solidays manifesto
This text was presented july 3rd at the press conference after the meeting of Solidarité Sida, Solidays, and 35 associations have already signed it.
06
07, 2002
Barcelona
Barcelona cannot be one more conference during which we hear people trot out slogans such as « close the gap », « end the silence on AIDS », « the expertise and commitment to act » without anything more crucial coming out of it. Barcelona cannot be one more conference during which we declare that people [...]
06
07, 2002
the pharmaceutical industry’s attempt to conquer Europe
The European Coalition on Medicine is a collective made up of associations supporting patients' and consumers' rights (including Act Up Paris), and of independent medical publications. It was created in order to fight a proposal that would change European policy on advertising and information related to medicine.
05
07, 2002
Where is the 10 billion dollars?
Contact: Gaëlle Krikorian: + 33 6 09 17 70 55/ 658 520 872 (Barcelona local number) Almost 10 000 people die of AIDS every day. Today we know how to fight the epidemic; we know that HIV-infected people in developing countries are not doomed, but can be kept alive; we know what treatments to implement. And [...]
04
07, 2002
post Doha
Last November at Doha the Member States of the WTO instructed the TRIPS Council to find a solution before the end of 2002 making it possible for generic producing countries to export generics to countries which aren't producing themselves. Now the European Commission and the Unites States of America, which play down the importance of universally [...]
27
06, 2002
AIDS and G8 : where is the 10 billion dollars?
A year after the Group of Eight Industrialized Countries announced the "historic" creation of a Global Fund to fight AIDS, the contribution of the richest countries does not reach one tenth of the goal set forth by Annan. Where is the ten billion dollars? There is almost no money left in the coffers of the Fund. In the past 12 months almost 3 million people have died of AIDS and the epidemic inexorably keeps spreading in size and scope.